Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis NOVO-B

Aristocrat - 25 or more consecutive years of dividend increases

Max Ratio

26.86

Dividend Yield

3.81 %

5Y Dividend Growth

173.00 %

Consecutive Years

30 years

5Y Average Payout Ratio

61.34 %

Dividend History NOVO-B

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 3.81 %
Consecutive Years 30
Forward Annual Dividend 11.65 DKK
Consistent Years 32
Dividend CAGR 3Y 29.91 %
Continuous Dividends
Dividend CAGR 5Y 22.25 %
Payout Ratio TTM 49.96 %
Dividend CAGR 10Y 16.38 %
Ex Dividend Date 08/15/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth NOVO-B

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin NOVO-B

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income NOVO-B

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM NOVO-B

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio NOVO-B

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Novo Nordisk A/S NOVO-B

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself NOVO-B

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 13.02
Forward PE 11.98
Enterprise Value Revenue 4.49
Price Sales TTM 4.28
Enterprise Value EBITDA 9.40
Price Book MRQ 7.95

Novo Nordisk A/S Dividends: 3.81 % Yield, History, Payment Schedule

NOVO-B
Current price
305.80 DKK +1 DKK (+0.33%)
Last closed 303.80 DKK
ISIN DK0062498333
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Copenhagen Exchange
Capitalization 1 352 614 667 989 DKK
Yield for 12 month -60.34 %
1Y
3Y
5Y
10Y
15Y
NOVO-B
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+290 980 751 409 DKK

Last Year

+232 723 078 970 DKK

Current Quarter

+75 125 163 369 DKK

Last Quarter

+77 009 905 584 DKK

Current Year

+246 370 175 710 DKK

Last Year

+196 886 925 161 DKK

Current Quarter

+57 185 543 689 DKK

Last Quarter

+64 138 348 704 DKK
EBITDA 165 822 243 409 DKK
Operating Margin TTM 44.35 %
Price to Earnings 13.02
Return On Assets TTM 21.11 %
PEG Ratio 1.60
Return On Equity TTM 71.47 %
Wall Street Target Price 2 560.31 DKK
Revenue TTM 316 230 879 479 DKK
Book Value 38.31 DKK
Revenue Per Share TTM
Dividend Share 11.67 DKK
Quarterly Revenue Growth YOY 5.10 %
Dividend Yield 3.81 %
Gross Profit TTM 263 857 900 824 DKK
Earnings per share 23.38 DKK
Diluted Eps TTM 23.38 DKK
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -26.50 %
Profit Margin 32.88 %

Technical Indicators NOVO-B

For 52 Weeks

267.43 DKK 777.45 DKK
50 Day MA 336.23 DKK
Shares Short Prior Month
200 Day MA 413.83 DKK
Short Ratio
Shares Short
Short Percent